Slate Path Capital LP - Q1 2018 holdings

$1.56 Billion is the total value of Slate Path Capital LP's 29 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 57.1% .

 Value Shares↓ Weighting
TWTR SellTWITTER INC$110,557,000
-34.7%
3,811,000
-45.9%
7.07%
-57.6%
CAR SellAVIS BUDGET GROUP$96,022,000
-14.4%
2,050,000
-19.8%
6.14%
-44.3%
X SellUNITED STATES STL CORP NEW$92,022,000
-20.3%
2,615,000
-20.3%
5.88%
-48.2%
ALNY SellALNYLAM PHARMACEUTICALS INC$44,663,000
-21.4%
375,000
-16.1%
2.86%
-48.9%
P SellPANDORA MEDIA INC$36,820,000
-31.9%
7,320,000
-34.7%
2.35%
-55.7%
GDX SellVANECK VECTORS ETF TRgold miners etf$6,638,000
-6.3%
302,000
-1.0%
0.42%
-39.2%
AKS ExitAK STL HLDG CORP$0-180,000
-100.0%
-0.10%
TRIP ExitTRIPADVISOR INC$0-74,000
-100.0%
-0.25%
WFTIQ ExitWEATHERFORD INTL PLC$0-2,800,000
-100.0%
-1.15%
NBR ExitNABORS INDUSTRIES LTD$0-1,720,000
-100.0%
-1.16%
APA ExitAPACHE CORP$0-610,000
-100.0%
-2.53%
DVN ExitDEVON ENERGY CORP NEW$0-635,000
-100.0%
-2.59%
PODD ExitINSULET CORP$0-565,000
-100.0%
-3.83%
DXC ExitDXC TECHNOLOGY CO$0-810,000
-100.0%
-7.56%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q1 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings